Nitin Sacheti of Papyrus Capital presented his in-depth investment thesis on Genesis Energy LP (US: GEL) at Best Ideas 2026.

Thesis summary:

Genesis Energy is an MLP operating offshore pipeline transportation in the Gulf of Mexico, marine transportation, and onshore services. Nitin highlights a corporate transformation driven by the sale of the company’s volatile soda ash business in Q2 2025 and the completion of a major pipeline capex cycle. These strategic shifts have eliminated the earnings obfuscation caused by historical commodity volatility and high spending, revealing a cleaner balance sheet and a stable, growing FCF structure anchored by three remaining business segments.

The company is now benefitting from a “flywheel effect” driven by rising earnings and declining capital intensity. The offshore pipeline segment, described as the “crown jewel,” features irreplaceable assets tied to deepwater drills with low lifting costs and high capacity utilization. As new projects like the CHOPS, Poseidon, and SYNC pipelines come online with take-or-pay contracts, volume ramps from developments such as Shenandoah and Salamanca will drive FCF growth. Concurrently, the marine transportation segment benefits from the Jones Act moat and a supply/demand imbalance that supports higher day rates, while the onshore business provides stable, fee-based logistics support.

A central pillar of the thesis is management’s newfound discipline regarding capital allocation. Rather than chasing high-priced acquisitions, the team is focused on deleveraging and addressing the capital structure, specifically retiring high-cost preferred equity with coupons exceeding 12%. The strategy involves modest 10-15% dividend growth in the near term, utilizing excess FCF to pay down preferreds and refinance debt. This financial engineering paves the way for a step-change in distributions, with a target payout ratio of 75% by 2027.

There appears to be limited downside risk to projections given the stable, contractual nature of the assets. The pipelines benefit from life-of-lease dedications, and the marine business is insulated by the prohibitive costs of new vessel construction and a lack of shipyard capacity. While a repeal of the Jones Act represents a theoretical risk, geopolitical dynamics make this unlikely. The primary variable is not fundamental earnings volatility, but rather the timing of capital allocation decisions as the company transitions toward a higher payout model.

The shares recently traded at $16, implying a near 50% discount to peers. Nitin estimates FCF will reach roughly $2.70 per share in 2027. The current valuation gap is largely a function of the depressed dividend yield during this deleveraging phase. However, as management executes its plan to increase the distribution to $2.00 per share in 2027, the stock is expected to re-rate. Applying a 7% yield to that future dividend implies a price of $28, offering ~75% upside.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Nitin Sacheti runs Papyrus Capital GP LLC where is he the Portfolio Manager. He is also the author of the book, Downside Protection: Process and Tenets for Short Selling in All Market Environments. Prior to founding Papyrus Capital GP LLC, Nitin was a Senior Analyst/Principal at Charter Bridge Capital where he managed the firm’s investments in the technology, media and telecom sectors as well as select consumer investments. Before Charter Bridge, Mr. Sacheti was a Senior Analyst at Cobalt Capital, managing the firm’s technology, media and telecom investments and a Senior Analyst at Tiger Europe Management. Mr. Sacheti began his investment career in 2006 at Ampere Capital Management, a consumer, media, telecom and technology focused investment firm, initially as a Junior Analyst, later becoming Assistant Portfolio Manager. He graduated from the University of Chicago with a BA in Economics, was a visiting undergraduate student in Economics at Harvard University and attended the Loomis Chaffee School.

Keith Smith of Bonhoeffer Fund discussed the successful use of leverage to boost long-term equity returns at Best Ideas 2026. Current opportunities discussed include Meritz Financial Group (Korea: 138040), Fairfax Financial Holdings (Canada: FFH), and Fidus Investment Corporation (US: FDUS). Historical examples include Berkshire Hathaway, Fairfax, and Shelby Davis.

Keith shares insights into a strategy that is often misunderstood and frequently shunned by conservative market participants: the successful application of leverage. While the history of finance is littered with stories of leverage gone wrong, Keith argues that a distinct group of value investors — from Shelby Davis to Warren Buffett — has utilized it as a primary engine for generational wealth creation. The presentation moves beyond the simplistic view of margin debt to explore the nuances of “structural leverage,” where the focus shifts to the arbitrage between the cost of liabilities and the yield of high-quality assets.

Keith deconstructs the mechanics behind this approach, illustrating how negative-cost float and low-fixed-rate debt can transform average investment returns into spectacular compounders. He challenges the notion that leverage is inherently reckless, positing instead that safety comes from the durability of the underlying cash flows and the terms of the borrowing, rather than the absence of debt itself. He dissects Buffett’s investment in Japanese trading houses as a masterclass in locking in spreads to secure returns with minimal equity exposure.

To ground these concepts in reality, Keith walks through real-time case studies of companies executing this playbook across the globe, from Korea to Canada. He analyzes the “virtuous circle” of underwriting profits fueling investment portfolios in the insurance sector and examines how Business Development Companies (BDCs) are navigating the risk-reward spectrum in private credit. This session offers a practical framework for identifying management teams that treat capital allocation as a spread business, aiming to replicate the success of historical greats in a modern market environment.

Thesis summary: Meritz Financial Group

Meritz is a Korean holding company that integrates a property and casualty (P&C) insurer with a brokerage firm to finance high-yield real estate debt. Keith notes that the company utilizes insurance float from long-term healthcare liabilities and brokerage deposits to fund investments in the double-B to single-B credit region, which academic studies identify as the optimal risk-reward location. The firm has transitioned its portfolio toward first-lien loans, which now comprise approximately 90% of origination, while maintaining expertise in distressed asset workouts. This structure allows the insurer to achieve scale and underwrite risk while the brokerage arm sources high-yielding assets, providing a 100 basis point advantage over P&C competitors.

The company has delivered a ten-year average ROE of roughly 21% and an incremental return on capital of 21%. Keith points out that as interest rates rose, investment yields improved from 3.7% to 4.6%, further supporting the company’s high investment leverage of roughly 9x. The business generates consistent float growth of around 4% annually, with deposit growth rates outpacing this figure. This operational leverage is supported by a combined ratio in the 90% range and a dominant market share in the long-term healthcare insurance sector.

Management alignment and corporate governance are central to the thesis, with the entrepreneurial chairman owning a majority of shares. Keith explains that Meritz was an early adopter of performance-based compensation and equity ownership in Korea, with management incentives tied to TSR and ROE targets. Top executives receive approximately 5% of net income, and dilution is kept modest at roughly 1.2%. The capital allocation strategy prioritizes share repurchases when the rate of return on investments exceeds the estimated 9% cost of capital; otherwise, the firm returns cash via dividends.

Valuation remains compelling given the company’s growth profile and capital efficiency. Keith highlights that the shares recently traded at approximately 5x earnings and 1.8x book value, despite the company generating the highest ROE in its peer group. With organic growth estimated at 4% plus operational leverage and annual buybacks of 5-6%, the firm offers a rare combination of high asset returns, low loss ratios, and substantial leverage at a discounted multiple.

Thesis summary: Fairfax Financial Holdings

Fairfax operates as an insurance holding company focused on property and casualty insurance, reinsurance, and investment management, with a 50-year history of acquiring underperforming insurers and improving their operations. Keith notes the company targets a 15% ROE and a combined ratio below 100% across the underwriting cycle. The business benefits from a “hard” insurance market, which has supported recent sales and earnings growth. The company utilizes a decentralized structure where acquired subsidiaries, such as Brit and Allied World, provide diversification across catastrophe risks and niche markets, with data and AI increasingly utilized to enhance underwriting efficiency.

A core component of the thesis is the investment of float, debt, and equity into a balanced portfolio, currently allocated approximately 74% to fixed income and 26% to equity. The shift toward a “higher for longer” interest rate environment has allowed Fairfax to lock in yields around 4-5% on the fixed income book, an increase from previous levels of 1.9%. Keith highlights that this fixed income yield, when applied to a portfolio levered 2.6 times, generates positive returns even without contribution from the equity book. The portfolio also includes exposure to emerging markets like India and Greece, leveraging the management team’s specific geographic expertise.

Recent performance reflects successful turnaround efforts, with acquired entities purchased at roughly 1.7x written premiums now valued lower relative to their premiums due to operational improvements. The company has achieved a 10-year average ROE of 15% and a Return on Incremental Invested Capital (ROIIC) of roughly 21%. Keith points to a cycle where higher investment returns allow the company to accept slightly higher combined ratios than competitors while maintaining profitability, thereby capturing market share. Reserve redundancies appear adequate, providing a safety margin and validating the conservative nature of the underwriting.

The company is led by Prem Watsa, who has served as CEO since 1985 and maintains alignment with shareholders through a 6.7% equity stake; total management ownership stands at approximately 9%. Executive compensation is weighted toward performance-based incentives with minimal cash draw, and stock grants result in low dilution. Capital allocation priorities include organic growth, acquisitions, and share repurchases, with the company buying back 4-5% of shares annually over the past five years.

Fairfax shares recently traded at a P/B of roughly 1.4x and an earnings multiple of 8.6x, representing a discount compared to peers such as WR Berkley and Intact Financial. Keith suggests that even with conservative assumptions—3% organic growth and 3% annual share repurchases—the stock implies potential annual returns of 20-30%. The valuation reflects a discount often applied to the company’s complex structure, despite evidence of improved underwriting discipline and an investment portfolio benefiting from the current rate environment.

Thesis summary: Fidus Investment Corporation

Fidus operates as a Business Development Company (BDC) focused on providing senior financing to lower middle-market firms for growth, acquisitions, and restructurings. Historically a mezzanine lender, Keith notes that the company has successfully transitioned its portfolio composition toward first-lien floating rate debt, which now comprises 72% of loans compared to just 30% five years ago. The firm differentiates itself through robust proprietary deal flow, sourcing 67% of investments internally rather than relying on widely syndicated transactions. This origination strategy allows Fidus to target growing enterprises rather than the flat or declining businesses often found in broader high-yield underwriting.

The investment strategy emphasizes defensive growth sectors, with 50% of loans structured against intangible assets such as recurring software revenue. Credit quality remains stable, evidenced by a steady portfolio interest coverage ratio of 3.0x and non-accruals limited to 0.3%. Keith highlights that while Fidus targets the B to double-B underwriting sweet spot to generate yield, it maintains conservative leverage with a debt-to-equity ratio of 0.7x. The company focuses on relationship continuity, retaining approximately 30% of follow-on business from existing clients, which helps mitigate the churn typically associated with BDC portfolios.

A key differentiator in the Fidus model is the systematic inclusion of equity positions alongside debt instruments. The firm holds equity stakes, typically ranging from 2% to 12%, in approximately 80% of its borrowers. This structure provides capital appreciation upside often absent in standard BDC models, where lenders typically bear downside risk without participating in equity value creation. Keith attributes roughly 300 basis points of annual return to these investment gains, driving a five-year TTM ROE of 13.6%, which exceeds the CCFLX benchmark of 10.2%. This approach has allowed Fidus to grow NAV over time, a rarity in a sector where high distributions often lead to declining book values.

Shares recently traded at approximately 8.4x earnings, implying an earnings yield of nearly 12% and a dividend yield of 10.9%. While the stock recently traded near its book value (P/BV ~1.01x), Keith argues that the combination of a high current yield and modest NAV growth supports a total return profile that warrants a higher multiple. Applying the Graham formula suggests a fair value multiple closer to 10.9x. The thesis anticipates a potential re-rating as the market recognizes the improved safety profile of the first-lien transition and the sustained ROE outperformance relative to larger peers.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Keith Smith, the fund manager, brings over 20 years of valuation experience to the Bonhoeffer Fund. He is a CFA charterholder and received his MBA from UCLA. Keith currently serves as a Portfolio Manager at Bonhoeffer Capital and was previously a Managing Director of a valuation firm and his expertise includes corporate transactions, distressed loans, derivatives, and intangible assets. Warren Buffett and Benjamin Graham’s value-oriented approach of pursuing the “fifty-cents on the dollar” opportunities, underpins Keith’s investment strategy. The combination of his experience and track record led Keith to commit most of his investable net worth to the Bonhoeffer Fund model.

Amit Wadhwaney of Moerus Capital Management presented his investment thesis on Natura Cosméticos (Brazil: NATU3) at Best Ideas 2026.

Thesis summary:

Natura is a Brazilian beauty and personal care company that dominates its home market, the fifth-largest globally, through a direct-selling model that emphasizes natural ingredients and sustainable sourcing. The company historically generated strong returns by focusing on Latin America, where it commands leading market share and leverages a network of 3.2 million consultants. However, a series of debt-funded acquisitions between 2013 and 2019 — Aesop, The Body Shop, and Avon — strained the balance sheet and diverted management attention from the core business. These missteps, compounded by macroeconomic challenges in key markets like Brazil and Argentina and the loss of Russian revenue, drove the stock to multi-year lows.

Amit argues that the current valuation obscures the resilience and profitability of the legacy Natura brand. Management has moved aggressively to repair the balance sheet by divesting Aesop and The Body Shop, effectively eliminating net debt. The problematic Avon acquisition is being restructured, with the international non-LatAm operations separated and the Latin American integration proceeding, albeit with short-term integration costs. The core Natura business in Brazil continues to perform well, with underlying margins around 19.5%, suggesting that once the “noise” of restructuring and write-downs subsides, the company’s earnings power will become visible again.

The thesis relies on a return to the company’s “circle of competence”—direct selling in Latin America—under new leadership and committed controlling shareholders. While the integration of Avon in Latin America presents execution risks, early signs of stabilization appeared in 2024 EBITDA results. The expectation is that as restructuring costs abate and macroeconomic headwinds in Brazil and Argentina potentially ease, the company will resume its historical trajectory of product innovation and profitability. The severe stock price decline reflects a “broken growth” narrative, but the underlying asset remains a dominant regional player with strong brand equity and a now-repaired balance sheet.

Regarding valuation, the shares recently traded at approximately 5.5x consensus 2025 EBITDA, a steep discount compared to global peers averaging around 18.8x and emerging market peers like AmorePacific at 10.5x. Even adjusting for the potential jettisoning of Avon, the core Natura business is valued at roughly 6.2x estimated normalized EBITDA. This valuation implies little to no credit for the turnaround or the inherent quality of the Natura franchise, offering a margin of safety for investors willing to look past near-term earnings volatility.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructors:

Amit Wadhwaney is a Portfolio Manager and Co-Founding Partner at Moerus Capital Management LLC, and the founding manager of the Moerus Worldwide Value Fund. Mr. Wadhwaney has over 30 years of experience researching and analyzing investment opportunities in developed, emerging, and frontier markets worldwide, and has managed global investment portfolios since 1996. Prior to founding Moerus, Mr. Wadhwaney was a Portfolio Manager and Partner at Third Avenue Management LLC. Mr. Wadhwaney founded the international business at Third Avenue and was the founding manager of the Third Avenue Global Value Fund, LP, the Third Avenue Emerging Markets Fund, LP, and the Third Avenue International Value Fund. Earlier in his career, Mr. Wadhwaney was first a securities analyst, and then Director of Research at M.J. Whitman LLC, a New York-based broker-dealer. Prior to joining M.J. Whitman, Mr. Wadhwaney was a paper and forest products analyst at Bunting Warburg, a Canadian brokerage firm. He began his career at Domtar, a Canadian forest products company. Mr. Wadhwaney holds an M.B.A. in Finance from The University of Chicago. He also holds a B.A. with honors and an M.A. in Economics from Concordia University; at Concordia, he was awarded the Sun Life Prize and the Concordia University Fellow in Economics, and he subsequently taught economics classes there. He also holds B.S. degrees in Chemical Engineering and Mathematics from the University of Minnesota.

Christian Billinger of Billinger Förvaltning presented his investment thesis on European spirits companies at Best Ideas 2026.

Thesis summary:

Christian presents a contrarian investment thesis on the European spirits sector, specifically focusing on the major listed players: Diageo, Pernod Ricard, Remy Cointreau, and Davide Campari-Milano. Historically regarded as high-quality compounders with robust brands, global distribution networks, and long growth runways, these companies generated approximately 15% TSR annually between the GFC and the onset of the pandemic. However, market sentiment has shifted dramatically, driving share prices down 60-85% from their peaks. This drawdown is primarily driven by fears of a structural decline in alcohol consumption, particularly in the U.S. Christian argues that these concerns are overstated and that the current valuation compression represents a cyclical downturn rather than a permanent impairment, offering an attractive entry point for long-term investors.

The bearish narrative centers on declining per capita consumption in the U.S., which has fallen 10-15% since peaking in 2022. Christian contends this decline must be viewed in the context of the exceptional, price-driven growth seen in 2020 and 2021, suggesting a normalization rather than a structural break. He notes that U.S. per capita consumption remained remarkably stable at 8-10 LPA for decades prior to the pandemic and that historical industry cycles—such as the 25% decline observed between the early 1980s and late 1990s—eventually reversed. Furthermore, volume is not the sole driver of returns; while global alcohol volumes have been flat over the last decade, the market value has grown 16%, driven by premiumization and positive category shifts where spirits have gained share from wine and beer.

The sector offers distinct exposures across the four main entities. Diageo and Pernod Ricard serve as large, diversified groups with broad global reach across categories and price points. In contrast, Remy Cointreau is a focused business with exposure to Cognac and the China/U.S. markets, while Campari acts as a hybrid with dominance in aperitifs and European exposure. Even within a flat aggregate market, specific brands and categories have delivered robust growth; for example, Tequila and brands like Don Julio and Aperol have achieved double-digit CAGRs over the last decade. Beyond top-line growth, Christian identifies opportunities for value creation through operational efficiencies and cost reductions, noting that the industry saw little operating leverage during the boom years.

Valuations have contracted significantly, with the diversified majors Diageo and Pernod Ricard recently trading at FCF yields of approximately 6-8%. The more focused entities, Campari and Remy Cointreau, recently traded at yields of roughly 5% and 3% respectively, reflecting their higher historical volatility and currently depressed earnings bases—Remy’s earnings, for instance, have fallen nearly 70%. While leverage remains a constraint for aggressive buybacks across the sector, Christian believes the current prices discount an overly negative scenario, providing an asymmetric opportunity if growth stabilizes or if management teams pivot effectively toward capital discipline and efficiency.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Christian Billinger is an Investor at Billinger Förvaltning, a family-held investment company with no external capital. The simplicity of the setup as well as permanent and patient capital provides Christian with the proper environment to pursue his strategy of identifying long term compounders.

Christian focuses first on the qualities of robustness and resilience which limit downside potential before determining the mix of returns on capital and scope for reinvestment opportunity that accounts for the upside. Often, these factors overlap with family-controlled management teams that more conservatively finance their operations.

Prior to Billinger Förvaltning, Christian worked as a European Equity Analyst for various investments funds. Before that, Christian was an associate at PwC. He holds an MS in Accounting and Finance from The London School of Economics as well as Karlstad University. He is also a CFA charterholder. He splits time between London and Sweden.

Kyle Mowery of GrizzlyRock Capital presented his in-depth investment thesis on AMN Healthcare Services (US: AMN) at Best Ideas 2026.

Thesis summary:

AMN is the largest diversified healthcare staffing provider in the U.S., offering a comprehensive suite of workforce solutions that includes nurse and allied staffing, physician placement, and technology-driven workforce management. The company operates in a cyclical industry that is currently emerging from a post-COVID trough, a period characterized by compressed bill-pay spreads as healthcare systems shifted toward permanent labor to rationalize costs. Recent data indicates an inflection point; demand for travel nurses has rebounded approximately 50% from mid-2025 lows, and bill rates have stabilized with early signs of improvement. AMN’s scale, combined with its integrated technology platform, positions it advantageously against smaller competitors and “tech-native” entrants that have struggled with profitability and fulfillment during the downturn.

Long-term demand is supported by robust secular tailwinds, specifically an aging demographic driving higher healthcare utilization against a backdrop of persistent shortages in clinical labor. AMN has strategically diversified its revenue mix, reducing reliance on traditional staffing by expanding into high-margin technology and workforce solutions which enhance client retention. While the upcoming renewal of the Kaiser contract—historically representing a notable portion of revenue—creates a perceived overhang, the depth of the relationship suggests a high probability of renewal. Furthermore, a growing pipeline of vendor management system (VMS) and managed service provider (MSP) opportunities in late 2026 offers additional avenues for margin expansion and revenue growth largely ignored by current street estimates.

Financially, AMN remains highly cash-generative throughout the cycle, averaging robust FCF even prior to its recent expansion into higher-margin segments. Although headline leverage appeared elevated at 3.9x LTM in late 2025 due to cyclically depressed earnings, the company has successfully termed out debt at attractive fixed rates. Management expects leverage to naturally deleverage to below 3.0x over the next four to six quarters as EBITDA recovers. This strong cash conversion profile provides flexibility for capital allocation, including potential share repurchases or accretive M&A in a fragmented market where private valuations are resetting.

Shares recently traded at approximately $16, implying a valuation of roughly 6.9x estimated 2026 EBITDA and a normalized FCF yield to equity approaching 25%. This valuation reflects a market consensus that likely underestimates the pace of the recovery in bill-pay spreads and volume demand. As the cycle turns and margins normalize toward historical averages, the disconnect between the current share price and the company’s intrinsic earnings power presents a compelling asymmetry, with potential for material upside as operating leverage takes hold and sentiment realigns with business fundamentals.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Kyle Mowery is the founder and managing partner of GrizzlyRock Capital. Kyle holds an MBA from the University of Chicago Booth School of Business and a BA in Economics from UCLA. GrizzlyRock takes a fundamental, value-oriented research approach focused on finding clarity within complexity in small cap companies. GrizzlyRock’s rigorous research and structured investment process provides a sturdy foundation for systematically identifying substantially mispriced securities with high risk/reward asymmetry.

Patrick Brennan of Brennan Asset Management presented his investment thesis on Metro Bank (UK: MTRO) at Best Ideas 2026.

Thesis summary:

Metro Bank is a UK-based challenger bank that has transitioned from a high-growth model to a distressed turnaround situation following a 2019 capital crisis and a subsequent recapitalization in late 2023 led by Spaldy Investments. Patrick argues that the bank possesses a durable “moat” in its deposit franchise, which features a cost of deposits significantly lower than peers at roughly 95 basis points and a high proportion of non-interest-bearing accounts. Following a 40% headcount reduction and aggressive cost-cutting measures implemented by CEO Dan Frumkin, the bank is pivoting its asset strategy to leverage this funding advantage. The turnaround is anchored by a majority shareholder with a track record in distressed financial investments and a management team heavily incentivized by a compensation plan that targets a share price roughly 3.5x higher than recent levels.

The investment thesis rests on three primary earnings drivers: asset rotation, treasury repricing, and regulatory capital relief. Patrick highlights the bank’s shift from low-yield residential mortgages to higher-margin commercial loans and specialist mortgages, targeting origination spreads of 350 basis points over base rates. Early results from H1 2025 indicate strong momentum with doubled corporate lending volumes. Simultaneously, the bank’s legacy portfolio of low-yielding treasury securities is maturing; rolling these assets into current market rates is projected to provide a cumulative 600 basis point uplift to ROE. This mechanical repricing alone is expected to drive returns on tangible equity from mid-single digits to low teens over the medium term.

A critical, hard catalyst for the thesis is Metro Bank’s exit from the MREL (Minimum Requirement for Own Funds and Eligible Liabilities) regime, effective January 1, 2026. This regulatory shift, resulting from an increase in the asset threshold for compliance, allows the bank to redeem £525 million of expensive debt carrying a 12% coupon. Patrick estimates this redemption will eliminate roughly £60 million in annual interest expense, contributing approximately 4% to the ROE uplift without requiring any new equity issuance. The market has largely ignored this event due to sparse sell-side coverage and broader negative sentiment toward UK financials.

While acknowledging macro risks related to the UK economy’s stagnation and potential housing market softness, Patrick suggests the valuation offers a substantial margin of safety. The bank’s “muddle along” scenario, which does not rely on aggressive economic recovery, still supports a path to a mid-to-high teen ROE. Furthermore, the strategic value of the deposit franchise makes Metro a logical acquisition target, providing downside protection. The alignment with Spaldy Investments, which owns over 50% of the bank, suggests a focus on eventual monetization or a sale, potentially to a private equity firm or a fintech looking to acquire a banking license and deposit base.

Metro Bank shares recently traded at approximately £1.25, representing roughly 0.6x to 0.75x tangible book value (TBV). Patrick believes this valuation is disconnected from the bank’s earnings power, projecting that the combination of treasury repricing, asset rotation, and the MREL cost savings could drive EPS to £0.40 by 2028. At a conservative multiple or through share buybacks executed at these depressed levels, the stock has the potential to triple. The disconnect between the current distressed multiple and the credible path to a 20% ROE presents a unique asymmetric opportunity in a market where the hard catalysts are already confirmed but not yet priced in.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

Patrick Brennan is the founder and portfolio manager of Brennan Asset Management, LLC (BAM), a Registered Investment Advisory firm based in Napa, CA, which utilizes a concentrated value investing strategy. Patrick has given presentations at multiple value investing conferences, including presentations to The New York Society of Security Analysts (NYSSA), The Nebraska Society of Securities Analysts and presentations on various names at the VALUEx Vail Conferences. Patrick co-authored an article on tracking stocks with Lawrence Cunningham for The Financial History Magazine and Patrick was featured in a write-up in The Private Investment Brief. Prior to founding Brennan Asset Management, Patrick managed portfolios and led research efforts at two value investing firms in California: Hutchinson Capital Management and RBO & Co.

Previously, Patrick worked at Mark Boyar & Company, where he led the firm’s research team and helped manage $800 million of assets across individual portfolios, institutional accounts and a mutual fund. Patrick also worked for six years in investment banking and equity research with Deutsche Bank, CIBC World Markets and William Blair & Company. Patrick graduated summa cum laude from the University of Notre Dame with a degree in economics and was inducted into Phi Beta Kappa. Patrick received the Chartered Financial Analyst (CFA) designation in 2002 and is a member of the CFA Institute (formerly AIMR). Patrick is originally from Omaha, Nebraska.

A.J. Noronha of Desai Capital Management presented his investment thesis on Cal-Maine Foods (US: CALM) at Best Ideas 2026.

Thesis summary:

Cal-Maine Foods is the dominant player in the U.S. specialty egg market, commanding a market share roughly double that of its nearest competitor. A.J. highlights the company’s vertically integrated supply chain—spanning feed production, farming, processing, and distribution—as a critical lever for cost control and bio-security mitigation against risks such as avian flu. While eggs are inherently a commoditized product, Cal-Maine has established defensible brand loyalty through recognized labels including Eggland’s Best and Land O’ Lakes. This market leadership is supported by a robust distribution network that penetrates nine of the top ten retail stores and eight of the top ten foodservice providers in the country.

The investment case is supported by favorable consumer trends and a shift in dietary guidelines that prioritize protein and healthy fats over grains. A.J. notes that despite recent volatility in egg pricing, which saw a decline of nearly 50% year-over-year, consumption demand remains resilient due to the relative affordability of eggs compared to beef, which remains near all-time highs. The company is capitalizing on these tailwinds by scaling its higher-margin specialty foods segment, including ready-to-eat options like egg wraps and breakfast sandwiches. Although the business is entirely focused on the domestic U.S. market, this concentration effectively insulates operations from international supply chain disruptions and tariffs.

Financially, the company maintains a conservative balance sheet characterized by a strong net cash position, which A.J. views as an objective floor for value. This liquidity provides flexibility for operational adjustments and capital allocation strategies, including M&A activity ranging from feed input companies to specialty food producers. Management utilizes this cash accumulation to support shareholder returns, maintaining a dividend policy targeting approximately one-third of earnings, which recently resulted in a yield exceeding 10%. Additionally, a share repurchase program representing roughly 7-8% of the total market cap offers a secondary mechanism to return capital when the stock price disconnects from fundamentals.

Regarding valuation, the shares recently traded near the bottom of their 52-week range around $73, implying a P/B of 1.3x and a P/S of 0.9x. A.J. argues the stock trades approximately 40% below intrinsic value, offering a margin of safety reinforced by the company’s tangible book value and cash reserves. Based on a DCF analysis and the potential for mean reversion in egg pricing, the thesis targets a price range of $120 to $126 over a two-to-four-year horizon. This creates an asymmetric risk-reward profile where the downside is buffered by the cash position and dividend yield, while the upside is driven by steady capital appreciation and continued margin expansion.

The full session is available exclusively to members of MOI Global.

Members, log in below to access the full session.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:

About the instructor:

A.J. Noronha, CFA has over ten years of investment management experience, and has worked closely with Mr. Desai since Desai Capital Management’s inception in 2013 with all aspects of the fund, with his primary responsibilities being equity research, due diligence, and developing investment theses for DCM’s portfolio.

He has been ranked as highly as #1 (Value), #6 (Long), and #9 (both Overall and North America) in SumZero’s independent analyst rankings, and his independent research on Dow Chemical was selected as one of their top ideas of 2015.. He served as an instructor for MOI Global’s Best Ideas 2018-present and Wide Moat Summit 2018, and was an invited participant (non finalist) in the 2017-2018 Sohn Conference Foundation Idea Contests, 2017 SumZero/Van Biema Value Partners Idea Challenge, and 2017-present SumZero Top Stocks Contest.

In addition to DCM, A.J. is involved with several early-growth stage private market funds. Prior to DCM, Mr. Noronha gained investment experience working for a mid-market PE/VC fund, and also co-founded and served in a C-level role for a biomedical engineering startup. He earned a degree in Finance, magna cum laude, from the University of Notre Dame, where he was selected to be a member of the prestigious Applied Investment Management honors finance course where students manage a portion of the University endowment under the guidance of the Chief Investment Officer, and also holds a JD with Dean’s List honors & a concentration in business enterprise (selected coursework taken through the Kellogg School of Management) from Northwestern University. He is a proud CFA Charterholder, is an active Candidate Member of the CFA Society of Chicago & serves on its Professional Development Advisory Group Board, and is a member of Irish Entrepreneurs & Harvard Alumni Entrepreneurs.